Celator's AML drug gets fast track; Piramal buys a CDMO in Kentucky;

@FierceBiotech: ICYMI: Exclusive: Constellation chops staff, plots go-it-alone strategy as Genentech option deadline looms. Report | Follow @FierceBiotech

@JohnCFierce: Alzheimer's investigators open a new front in BACE1 war. More from FierceBiotechResearch | Follow @JohnCFierce

@DamianFierce: A CF patient taking 's Kalydeco will be a guest of Michelle Obama at the State of the Union tonight. More | Follow @DamianFierce

> Ewing, NJ-based Celator Pharmaceuticals ($CPXX) says that the FDA granted fast-track designation for CPX-351 (cytarabine:daunorubicin) for the treatment of elderly patients with secondary acute myeloid leukemia. Release

> India's Piramal Enterprises said it was on the cusp of buying a CDMO founded at the University of Kentucky. Report

Medical Device News

@FierceMedDev: ICYMI: Researchers develop needle-free temporary tattoo for glucose monitoring. Article | Follow @FierceMedDev

@VarunSaxena2: Piramal buys Coldstream - The HinduMore | Follow @VarunSaxena2

@EmilyWFierce: Carmat notches a win as artificial heart patient returns home. More | Follow @EmilyWFierce

> FDA to avoid regulating most wearables, seeking to reduce medical device regulation overall. News

> India opens medical device industry to foreign direct investment. Report

Pharma News

@FiercePharma: MSF urges GSK, Pfizer to slash pneumococcal vaccine prices. Report from FierceVaccines | Follow @FiercePharma

@CarlyHFierce: ICYMI: Actavis working to add Allergan CEO Pyott to board: Reuters. Story | Follow @CarlyHFierce

> J&J's pharma unit 'fastest-growing' in the drug business, CEO Gorsky says. Report

> GlaxoSmithKline rejected e-cig buy to beef up stop-smoking franchise. Article

Biotech IT News

> Personalis raises $33M to scale up pharma-facing genomics operation. Report

> 10X Genomics exits stealth mode with $80M, plan to improve Illumina tech. News

> Novartis teams with Qualcomm on $100M digital health fund. Item

> Genentech teams with Venter's HLI as Roche group continues genomics push. Story

> 23andMe inks Pfizer deal, eyes 2015 resolution of FDA dispute. Article

CRO News

> Clinipace banks $50M to scout for more deals. Story

> Evotec strikes an R&D deal focused on addiction. More

> AMRI inks a 10-year NIH deal with $37M on the line. News

> Ergomed posts a big year with more in store for 2015. Article

> Sanofi taps Catalent for antibody R&D. Report

Animal Health News

> Annual sales of animal health products stable at $7.5B. Item

> China bans import of U.S. poultry products on avian flu fear. Report

> Microbiome dealmaking hits animal health with Metanome-Companion PBx linkup. More

> PetMed's sales fall but profit margins expand on rising demand for pricier products. Story

> Zoetis, IDEXX, Schein among animal health scene-stealers at JP Morgan confab. Article

Biotech Research News

> Genetic error highlights a new approach to Fragile X syndrome. Report

> Microbiome research opens a new pathway for autoimmune disease. Article

> Tracking tech illuminates T cells for immuno-oncology research. Item

> Michigan investigators finger ATDC gene for aggressive pancreatic cancer. Story

> Alzheimer's investigators open a new front in BACE1 war. More

Pharma Manufacturing News

> Actavis recalling 65,000 bottles of generic seizure drug. News

> FDA raises issues with another Apotex plant. Article

> India makes move to reduce reliance on Chinese APIs. Item

> Boehringer Ingelheim picks up contract work for Sanofi mAbs. News

> India's Piramal says it will snatch up university CDMO for its injectables skills. Report

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.